相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Trastuzumab In HER2-Positive Metastatic Gastric Cancer
Jamie D. Croxtall et al.
DRUGS (2010)
HER-2 amplification is highly homogenous in gastric cancer
Michael Bilous et al.
HUMAN PATHOLOGY (2010)
A study of HER2 gene amplification and protein expression in gastric cancer
Benedict Yan et al.
JOURNAL OF CLINICAL PATHOLOGY (2010)
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
Yung-Jue Bang et al.
LANCET (2010)
Targeted HER2 Treatment in Advanced Gastric Cancer
Jan Trost Jorgensen
ONCOLOGY (2010)
HER2 diagnostics in gastric cancer-guideline validation and development of standardized immunohistochemical testing
Josef Rueschoff et al.
VIRCHOWS ARCHIV (2010)
Genotypic Intratumoral Heterogeneity in Breast Carcinoma With HER2/neu Amplification
Matteo Brunelli et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2009)
Association of ERBB2 gene status with histopathological parameters and disease-specific survival in gastric carcinoma patients
J. D. Barros-Silva et al.
BRITISH JOURNAL OF CANCER (2009)
HER-2 amplification is highly homogenous in gastric cancer
Andreas H. Marx et al.
HUMAN PATHOLOGY (2009)
Guidelines for Human Epidermal Growth Factor Receptor 2 Testing: Biologic and Methodologic Considerations
Guido Sauter et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Emerging Role of Capecitabine in Gastric Cancer
Pasquale Comella et al.
PHARMACOTHERAPY (2009)
Comparison of immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) assessment for Her-2 status in breast cancer
Weiguo Sui et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2009)
HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target
C. Gravalos et al.
ANNALS OF ONCOLOGY (2008)
Assessment of a HER2 scoring system for gastric cancer:: results from a validation study
M. Hofmann et al.
HISTOPATHOLOGY (2008)
Chemotherapy for metastatic gastric cancer: past, present, and future
Atsushi Ohtsu
JOURNAL OF GASTROENTEROLOGY (2008)
Drug therapy: Trastuzumab - Mechanism of action and use in clinical practice
Clifford A. Hudis
NEW ENGLAND JOURNAL OF MEDICINE (2007)
2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial
Ian Smith et al.
LANCET (2007)
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer
Antonio C. Wolff et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Evaluation of HER-2 gene status in gastric carcinoma using immunohistochemistry, fluorescence in situ hybridization, and real-time quantitative polymerase chain reaction
Min A. Kim et al.
HUMAN PATHOLOGY (2007)
Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer
David Cunningham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Chemotherapy in advanced gastric cancer: A systematic review and meta-analysis based on aggregate data
Anna D. Wagner et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
The ErbB receptors and their ligands in cancer: An overview
N Normanno et al.
CURRENT DRUG TARGETS (2005)
ERBB receptors and cancer: The complexity of targeted inhibitors
NE Hynes et al.
NATURE REVIEWS CANCER (2005)
Survival after gastric adenocarcinoma resection: Eighteen-year experience at a single institution
SC Cunningham et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2005)
Real-time reverse transcription-PCR and fluorescence in-situ hybridization are complementary to understand the mechanisms involved in HER-2/neu overexpression in human breast carcinomas
I Vanden Bempt et al.
HISTOPATHOLOGY (2005)
Status of c-erbB-2 in gastric adenocarcinoma:: A comparative study of immunohistochemistry, fluorescence in situ hybridization and enzyme-linked immuno-sorbent assay
T Takehana et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.
DJ Slamon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
c-erbB-2 is of independent prognostic relevance in gastric cancer and is associated with the expression of tumor-associated protease systems
H Allgayer et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
分享论文
